Research Paper Volume 11, Issue 18 pp 7817—7829
PRL-3 exerts oncogenic functions in myeloid leukemia cells via aberrant dephosphorylation of stathmin and activation of STAT3 signaling
Figure 4. Effects of PRL-3-silencing on cell migration and invasion were evaluated in K562 and K562/G01 cells. (A) The OD values (proportional to cell numbers) of migrated cells were measured by MTS assay. (B) The invasion cell numbers were counted under microscope in five HP fields. (C) Wright-Giemsa stained invasion cells were observed under microscope (×200). (D, E) Quantification of MMP2 and MMP9 were normalized to β-actin. (F) MMP2, MMP9, PRL-3 and β-actin expression by western blot. (*P<0.05, **P<0.01, vs. NC group).